L. Giacinti

The histone deacetylace inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen

Eun Ryoung Jang, Y. Bang, G. Jeong, 2004 .

High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.

C. Leonetti, P. Foggi, D. Giannarelli, 2006, Journal of experimental & clinical cancer research : CR.

Clinical trials.

A. Giordano, Massimo Lopez, L. Giacinti, 2019, Frontiers in Bioscience.

Epigenetic information and estrogen receptor alpha expression in breast cancer.

A. Giordano, P. Claudio, Massimo Lopez, 2006, The oncologist.

Scriptaid effects on breast cancer cell lines

A. Giordano, C. Giacinti, E. Rizzuto, 2012, Journal of cellular physiology.

The Medical Oncologist’s Point of View

Massimo Lopez, S. Fattoruso, L. Giacinti, 2009 .

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

D. Giannarelli, D. Sergi, L. di Lauro, 2009, Journal of experimental & clinical cancer research : CR.

Epigenome: a new target in cancer therapy.

P. Vici, M. López, L. Giacinti, 2008, La Clinica terapeutica.